Mayor Michelle Wu’s administration and Boston’s public employee unions are in a high-stakes standoff over how to handle soaring costs for GLP-1 weight-loss drugs, with City Hall warning the bill could blow a serious hole in next year’s benefits budget. The clash erupted after the city’s Public Employee Committee (PEC) voted down a package of cost-control changes last week, leaving officials to consider everything from new utilization-management rules to cutting weight-loss coverage entirely. Both sides are casting the fight as a battle between fairness and fiscal reality, and the result will ripple through both employee premiums and the city’s bottom line.
Ashley Groffenberger, the city’s chief financial officer, told PEC leaders that GLP-1 spending is projected at roughly $31.6 million for fiscal 2026 and could climb to about $47.4 million in fiscal 2027. Those drugs are helping drive a nearly $80 million jump in employer health costs across the city, Boston Public Schools and the Boston Public Health Commission. According to the city, GLP-1 use accounts for about 14.7% of the FY26 to FY27 cost increase, and roughly 7.7% of non-Medicare plan members are using the drugs for weight loss, a trend that would mean higher premiums for many workers. Under the administration’s scenario, an employee on the most-used non-Medicare plan would see monthly premiums rise from $655 to $803, an increase of about $148 a month, or $1,733 a year, unless the city and unions agree to rein in costs, according to the Boston Herald.
“The consequences of this inaction, if allowed to stand, are massive and immediate,” Groffenberger wrote in a letter to PEC leaders, warning of steep budget impacts if Boston keeps covering GLP-1s at current use levels. PEC leadership rejected the administration’s initial offer in a March 9 vote, with three major unions, including the Boston Teachers Union and Boston Firefighters Local 718, leading the effort to send it back. That stalemate has the city weighing tougher measures and pressing unions to return for a follow-up vote to decide what comes next, per the Boston Herald.
What the City Proposed
City officials told PEC leaders they had put forward a set of ideas to curb pharmacy spending, with the marquee change being new utilization-management rules for GLP-1s. Those rules would limit prescribing to cases that meet clinical criteria and tighten approvals through the pharmacy benefit manager. The administration is pitching utilization management as an industry-standard cost-control tool that ensures prescription drugs are used only when clinically appropriate, while still preserving access for patients who medically need them. Officials say that approach is a way to avoid slashing the benefit entirely, but unions counter that these rules can still make it harder for people who genuinely need the medications to get them.
Regional Context
Boston’s fight is unfolding as the state takes its own hard line. In late February, the Group Insurance Commission voted to eliminate GLP-1 coverage for weight loss in the state plan, a move supporters say is necessary to rein in runaway drug spending and critics warn will deepen health inequities. Those changes at the GIC, along with similar moves by several commercial insurers, are putting pressure on cities and towns to either rethink benefits or swallow sharp premium hikes at the bargaining table, according to WBUR. The statewide pullback gives Boston some leverage with drug makers, but it also ramps up political heat from union leaders and patient advocates.
Unions’ Objections and Next Steps
Union leaders argue that cutting back GLP-1 coverage effectively shifts the costs onto workers and risks widening disparities for employees who cannot afford to pay out of pocket, especially when many describe the drugs as life-changing. Labor representatives say PEC’s rejection of the city’s proposal was about protecting benefits won over years of negotiations and forcing the administration back to the bargaining table instead of allowing unilateral cuts. The city has asked PEC leadership to hold another vote by this Friday on whether to adopt utilization management or pursue other coverage changes, and both sides say talks will continue into next week as they try to avoid a sharp premium shock…